US Stock MarketDetailed Quotes

RPTX Repare Therapeutics

Watchlist
  • 1.770
  • -2.200-55.42%
Close Dec 13 16:00 ET
  • 1.830
  • +0.060+3.39%
Post 19:59 ET
75.24MMarket Cap-0.89P/E (TTM)

Repare Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Repare Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.341M--
--2024/Q4-- / 2.733M--
--2024/Q30.000 / 2.733M--
--2024/Q21.073M / 2.929M--
--2024/Q152.404M / 38.400M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.341M--
--2024/Q4-- / 2.733M--
--2024/Q30.000 / 2.733M--
--2024/Q21.073M / 2.929M--
--2024/Q152.404M / 38.400M--

Unlock Free Earnings Estimates

Repare Therapeutics Earnings Reports

  • Repare Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 07:18 ET

  • Repare Therapeutics | 8-K: Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results

    Nov 7 07:13 ET

  • Repare Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:24 ET

  • Repare Therapeutics | 8-K: Repare Therapeutics Provides Business and Clinical Update and Reports Second Quarter 2024 Financial Results

    Aug 6 16:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 15, 2024

    Buy

    • Buy

      71.43%

    • Hold

      28.57%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data